Protective effects of ticlopidine and aspirin, administered alone and in combination, on thrombus formation in rat cerebral vessels

Pathophysiology of Haemostasis and Thrombosis

Volumn 26, Issue 3, 1996, Pages 150-156

  Sasaki, Yasuto ^a   Ishii, Izumi ^a   Addings, John C ^b   Yamamoto, Junichiro ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Cerebral vessels; d; Helium neon laser; L Lysine acetylsalicylate; Ticlopidine

Indexed keywords

LYSINE ACETYLSALICYLATE; TICLOPIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD VESSEL; CONTROLLED STUDY; DRUG POTENTIATION; DRUG THERAPY; NONHUMAN; ORAL DRUG ADMINISTRATION; PREVENTION; PRIORITY JOURNAL; RAT; THROMBOGENESIS; THROMBOSIS;

ANIMALS; ASPIRIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FIBRINOLYTIC AGENTS; INTRACRANIAL EMBOLISM AND THROMBOSIS; LYSINE; PLATELET AGGREGATION INHIBITORS; RATS; RATS, WISTAR; TICLOPIDINE;

EID: 0029999827     PISSN: 14248832     EISSN: 14248840     Source Type: Journal    
DOI: 10.1159/000217200     Document Type: Article

References (24)

1. De Caterina R, Sicari R, Bernini W, Lazzerini G, Strata GB, Gianessi D: Bcnefit/risk profile of combined antiplatelet therapy with ticlopidine and aspirin. Thromb Hacmost 1991;65:504-510.
2. McTavish D, Faulds D, Goa KL: Ticlopidine an updated review of its pharmacology and therapeutic use in platelet-dependent disorders. Drugs 1990;40:238-259.
3. Schrôr K: The basic pharmacology of ticlopidine and clopidogrel. Platelets 1993;4:252-261.
4. Di MinnoG, Cerbone AM, Mattioli PL, Turco S, lovinc C, Mancini M: Functionally thrombasthénie state in normal platelets following the administration of ticlopidine. J Clin Invest 1985;75:328-338.
5. Ashida S-I, Abiko Y: Inhibition of platelet aggregation by a new agent, ticlopidine. Thromb Haemost 1978; 40:542-550.
6. Ashida S-I, Abiko Y: Mode of action of ticlopidine in inhibition of platelet aggregation in the rat. Thromb Haemost 1979;41:436-449.
7. Cattaneo M, Akkawat B, Leechi A, Cimminiello C, Capitanio AM, Mannuci PM: Ticlopidine selectively inhibits human platelet responses to adenosine diphosphate. Thromb Haemost 1991;66:694-699.
8. Coller BS: Antiplatelet agents in the prevention and therapy of thrombosis. Annu Rev Med 1992;43:171-180.
9. Hirsh J. Salzman EW, Harker L, Fuster V, Dalen JE, Cairns JA, Collins R: Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects. Chest 1989;95:12S-18S.
10. The Steering Committee of the Physicians’ Health Study Research Group: Preliminary report: Findings from the aspirin component of the ongoing physicians’ health study. N Engl J Med 1988;318:262-264.
11. Sze PC, Rcitman D, Pincus MM, Sacks HS, Chalmers C: Antiplatelet agents in the secondary prevention of stroke: Meta-analysis of the randomized control trials. Stroke 1988; 19:436-442.
12. Alberts GW: Role of ticlopidine for prevention of stroke. Stroke 1992; 23:912-916.
13. Grotta JC, Norris JW, Kamm B, Tass Baseline and Angiographic Data Subgroup: Prevention of stroke with ticlopidine: Who benefits most? Neurology 1992;42:111-115.
14. Hass WK, Easton JD, Adams HP Jr, Pryse-Phillips W, Molony BA, Anderson S, Kamm B for the Ticlopid-ine Aspirin Stroke Study Group: A randomized trial comparing ticlo-pidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989; 321:501-507.
15. Bellavance A, for the Ticlopidinc Aspirin Stroke Study Group: Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study. Stroke 1993; 24:1452-1457.
16. Tohgi H: Theeffectofticlopidineon TIA compared with aspirin: A double-blind, twelve-month follow-up study. Agents Actions 1984; 15(suppl):279-282.
17. Uchiyama S, Sone R, Nagayama T, Shibagaki Y, Kobayashi I, Maruya-ma S, Kusakabe K: Combination therapy with low-dose aspirin and ticlopidine in cerebral ischemia. Stroke 1989;20:1643-1647.
18. Sasaki Y, Morii S, Yamashita T, Yamamoto J: Antithrombotic effect of argatroban on the pial vessels of the rat: A study with He-Ne laser-induced thrombus formation. Haemostasis 1993;23:104-111.
19. Maruyama I, Bell CE, Majerus PW: Thrombomodulin found in endothelium of arteries, veins, capillaries and lymphatics, and on syncytiotro-phoblast of human placenta. J Cell Biol 1985;101:363-371.
20. Ishii H, Salem HH, Bell CE, Laposta EA, Majerus PW: Thrombomodulin, and endothelial anticoagulant protein, is absent from the human brain. Blood 1986;67:362-365.
21. Morii S, Ngai AC, Winn HR: Reactivity of rat pial arterioles and venules to adenosine and carbon dioxide: With detailed description of the closed cranial window technique in rat. J Cereb Blood Flow Mctab 1986;6:34-41.
22. Yamamoto J. Ishii I, Sasaki Y, Na-gamatsu Y, Matsuda T, Ando E: Antithrombotic effects of ticlopidine on He-Ne laser-induced thrombus formation in rat mesenteric microvessels. Haemostasis 1992;22:147-152.
23. Gachct C, Ohlmann P, Maffrand J-P, Jakobs KH, Cazenavc J-P: ADP receptor induced activation of guanine nucleotide binding proteins in rat platelet membranes-An effect selectively blocked by the thicnopy-ridine clopidogrel. Thromb Hae-most 1992;68:70-83.
24. Derian CK, Friedman PA: Effect of ticlopidine ex vivo on platelet intracellular calcium mobilization. Thromb Haemost 1988;50:65-76.